Valiant Laboratories Limited (BOM:543998)
121.40
-3.55 (-2.84%)
At close: Oct 7, 2026
Valiant Laboratories Market Cap
Valiant Laboratories has a market cap or net worth of 6.56 billion as of October 7, 2026. Its market cap has increased by 47.09% in one year.
Market Cap
6.56B
Enterprise Value
6.69B
Revenue
3.06B
Global Rank
n/a
Country Rank
n/a
PE Ratio
42.18
ChartMarket Cap Chart
Since October 6, 2023, Valiant Laboratories's market cap has decreased from 7.40B to 6.56B, a decrease of -11.28%. That is a compound annual growth rate of -3.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 6.56B | 72.62% |
| Dec 31, 2025 | 3.80B | -21.26% |
| Dec 31, 2024 | 4.83B | -35.84% |
| Dec 29, 2023 | 7.53B | 1.73% |
| Oct 6, 2023 | 7.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bharat Parenterals | 11.84B |
| Lincoln Pharmaceuticals | 11.66B |
| Sudarshan Pharma Industries | 9.48B |
| Anuh Pharma | 8.71B |
| Kilitch Drugs (India) | 7.55B |
| ZIM Laboratories | 7.31B |
| Wanbury | 6.95B |
| Albert David | 4.86B |